<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>alpha-synuclein fibril injection causes synucleinopathy (prodromal Parkinson&amp;#x27;s disease model) — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>alpha-synuclein fibril injection</strong>
  <span class="pred">&mdash;causes&rarr;</span>
  <strong>synucleinopathy (prodromal Parkinson&#x27;s disease model)</strong>
</div>
<div class="entity-id">UNKNOWN:alpha-synuclein fibril injection &nbsp;&middot;&nbsp; MESH:D010300</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 50.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.0 (Physical) &times; log&#8322;(1+1) = 10.00<br>Incoming citations: 6 &rarr; score 50.00</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1021/acs.jproteome.8b00224">10.1021/acs.jproteome.8b00224</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS640">MTBLS640</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 6 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:33px"></span><span>1</span><span class="cite-subtotal">&middot; +8.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Taurocholic acid — is_biomarker_for → Sporadic Parkinson&#x27;s Disease</span><span class="cite-claim-weight">+8.00</span><a href="../claim/4b03166088bb86d9.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:67px"></span><span>2</span><span class="cite-subtotal">&middot; +24.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CSF bile acid metabolites — distinguishes → Parkinson&#x27;s Disease</span><span class="cite-claim-weight">+12.00</span><a href="../claim/5045661b34037ba0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CSF metabolome profile — distinguishes → Sporadic Parkinson&#x27;s Disease vs LRRK2 Parkinson&#x27;s Disease</span><span class="cite-claim-weight">+12.00</span><a href="../claim/bebec0778a8e1a8b.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:100px"></span><span>3</span><span class="cite-subtotal">&middot; +18.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Glycochenodeoxycholic acid — is_biomarker_for → Sporadic Parkinson&#x27;s Disease</span><span class="cite-claim-weight">+6.00</span><a href="../claim/17a230e4ba32b49e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Glycocholic acid — is_biomarker_for → Sporadic Parkinson&#x27;s Disease</span><span class="cite-claim-weight">+6.00</span><a href="../claim/cd915643205d8512.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Taurochenodeoxycholic acid — is_biomarker_for → Sporadic Parkinson&#x27;s Disease</span><span class="cite-claim-weight">+6.00</span><a href="../claim/f5e8dbd9a83254ef.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>a64fad749d344564</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:alpha-synuclein fibril injection">UNKNOWN:alpha-synuclein fibril injection</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D010300">MESH:D010300</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
